Literature DB >> 19026297

Emergency pretreatment for contrast allergy before direct percutaneous coronary intervention for ST-elevation myocardial infarction.

C Randall Hubbard1, James C Blankenship, Thomas D Scott, Kimberly A Skelding, Peter B Berger.   

Abstract

Patients with previous adverse contrast reactions occasionally present with ST-segment elevation myocardial infarction. Whether they can undergo catheterization safely using current contrast and medications is unknown. We reviewed catheterization laboratory records of all 501 patients (January 2005 to December 2006) presenting with ST-segment elevation myocardial infarction who underwent emergency coronary angiography. Six patients (1.2%) reported a previous contrast reaction including rash, acute bronchospasm, or anaphylaxis. All received a combination of intravenous steroids and H1 and H2 blockers in the emergency department or catheterization laboratory before catheterization. None of these had complications or evidence of allergy in any patient. In conclusion, some patients with previous contrast reaction may undergo emergency catheterization without adverse consequences, although the safety of this approach has not been proved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026297     DOI: 10.1016/j.amjcard.2008.07.040

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Safety and tolerability of iopromide in patients undergoing cardiac catheterization: real-world multicenter experience with 17,513 patients from the TRUST trial.

Authors:  Ji-Yan Chen; Yong Liu; Ying-Ling Zhou; Ning Tan; Bin Zhang; Ping-Yan Chen; Li-Bing Chen
Journal:  Int J Cardiovasc Imaging       Date:  2015-06-10       Impact factor: 2.357

2.  Zero-contrast percutaneous coronary intervention for chronic total occlusions guided by intravascular ultrasound with ChromaFlo mode: a case report.

Authors:  Chen-Yang Chen; Wei Huang; Jun Liu; Yu Cao
Journal:  Eur Heart J Case Rep       Date:  2020-11-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.